Integrated DNA Technologies Expands DNA Synthesis Capabilities to Support Genomics Programs Across Scale and Complexity Integrated DNA Technologies (IDT), a Danaher company and global provider of genomics solutions, has announced an expansion of its DNA synthesis capabilities designed to address…
BioTalent Canada and Montréal InVivo Strengthen Partnership to Expand Life Sciences Workforce Development BioTalent Canada and Montréal InVivo have announced an expanded partnership designed to strengthen workforce development across Canada’s life sciences and health technology (LSHT) sector. As part of…
bioAffinity Technologies Expands Government Healthcare Reach Through Distribution Agreement with AvMEDICAL for CyPath Lung bioAffinity Technologies, Inc., a biotechnology company focused on developing noninvasive diagnostic solutions for the early detection of lung cancer and other pulmonary diseases, has announced a…
Ingenia Therapeutics Begins KOSDAQ Trading to Advance Vascular-Targeted Therapy Pipeline Ingenia Therapeutics, a clinical-stage biotechnology company focused on developing next-generation vascular-targeted therapies, has announced that its shares have begun trading on South Korea’s KOSDAQ market, marking a significant milestone in…
Radiation Detection Company Launches Radiant Real-Time Dosimetry Solution to Enhance Radiation Safety in Medical Settings Radiation Detection Company (RDC), a long-established provider of occupational radiation dosimetry services, has announced the launch of Radiant, a real-time electronic dosimetry solution designed to…
Enhertu Demonstrates Significant Progression-Free Survival Benefit in First-Line HER2 Mutant Metastatic NSCLC Daiichi Sankyo and AstraZeneca have announced positive topline results from the Phase 3 DESTINY-Lung04 trial, demonstrating that Enhertu® (trastuzumab deruxtecan) significantly improved progression-free survival (PFS) compared with the…
EMA Validates Pfizer and Valneva’s Marketing Authorization Application for Lyme Disease Vaccine Candidate Pfizer Inc.and Valneva SE have announced an important regulatory milestone for their investigational Lyme disease vaccine candidate, PF-07307405, after the European Medicines Agency (EMA) validated the companies’…
biomodal Launches duet mosaic Workflows to Unlock More Biological Signals from Every Liquid Biopsy Sample biomodal, an omics-focused life sciences technology and analytics company, has announced the launch of its new duet mosaic family, a portfolio designed to help researchers…
LeAnn Rimes to Join Next Health Longevity Summit in Nashville, Bringing Personal Perspective to the Future of Health Optimization With just one month remaining until the inaugural Next Health Longevity Summit, Next Health, a global leader in health optimization and…
GeneDx Launches Online Exome Testing Offering to Expand Access to Genetic Diagnosis for Children GeneDx , a leader in rare disease diagnosis and genomic data, has announced the launch of a new digital offering designed to make exome testing more…
BioVigil Surpasses 1 Billion Hand Hygiene Opportunities, Highlighting Continued Focus on Infection Prevention and Patient Safety BioVigil, a leading provider of automated hand hygiene monitoring and infection prevention technology, has announced that its platform has recorded more than 1 billion…
Innate Pharma and Sobi Partner to Advance Lacutamab into Phase 3 Development for Cutaneous T-Cell Lymphoma Innate Pharma SA and Swedish Orphan Biovitrum AB (publ), widely known as Sobi®, have entered into a strategic partnership designed to accelerate the clinical…